News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Teva Pharmaceutical Industries Limited (TEVA) Receives FDA Close-Out Letter Over Jerusalem Plant


9/13/2011 7:43:20 AM

Teva Pharmaceutical Industries said it received a close-out letter from the U.S. Food and Drug Administration notifying the company that it has addressed issues raised following an inspection of its Jerusalem plant.The issues had been raised by the FDA in a warning letter received on Jan. 31 connected with an FDA "Good Manufacturing Practices" inspection of the oral solid dosage plant in Jerusalem. "The FDA completed a reinspection of the company's Jerusalem facility on June 19, 2011, which resulted in no adverse findings," Israel-based Teva said on Tuesday.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES